Shuqian Jing is the founder of Gmax Biopharm. Gmax Biopharm has raised $78M in total funding. Latest round: Series C. Based in Hangzhou, China.
Shuqian Jing is the founder, Chairman, and CEO of Gmax Biopharm, a clinical-stage biopharmaceutical company based in Hangzhou, China. The company develops monoclonal antibodies and M-Body therapeutics targeting G-protein coupled receptors to treat unmet medical needs, with a focus on cardiovascular diseases, metabolic disorders, and oncology. Gmax Biopharm has raised $78 million in a Series C financing round led by China Merchants Group.
Full founder directory · Investor directory · Company funding database · Fundraising library